iPSCs in NK Cell Manufacturing and NKEV Development

Natural killer (NK) cell immunotherapies for cancer can complement existing T cell therapies while benefiting from advancements already made in the immunotherapy field. For NK cell manufacturing, induced pluripotent stem cells (iPSCs) offer advantages including eliminating donor variation and provid...

Descripción completa

Detalles Bibliográficos
Autores principales: Boyd-Gibbins, Nicholas, Karagiannis, Peter, Hwang, Do Won, Kim, Shin-Il
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305199/
https://www.ncbi.nlm.nih.gov/pubmed/35874677
http://dx.doi.org/10.3389/fimmu.2022.890894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305199/
https://www.ncbi.nlm.nih.gov/pubmed/35874677
http://dx.doi.org/10.3389/fimmu.2022.890894

Ejemplares similares